Subscribe
11 July 2025NewsCareersMuireann Bolger

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’

New hire is deeply involved in the litigation space and has co-founded two software businesses.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
Powell Gilbert launches Düsseldorf office with leading patent litigator
11 July 2025   Major team hire by premier European litigation firm | September opening adds to successful UPC practice | Hire is a ‘landmark’ moment says Penny Gilbert.
Careers
Kilpatrick adds ‘seasoned litigator’ as trademark partner
10 July 2025   The new partner brings more than 30 years’ experience, including in counselling pharmaceutical, life sciences, and medical device companies.
Europe
Lord Justice Birss to become chancellor of the High Court
2 July 2025   The prominent senior IP judge is known for his groundbreaking judgments on patents, AI and FRAND, such as Unwired Planet, Thaler's DABUS, and InterDigital.


Editor's picks

Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025

Editor's picks

Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025
Europe
UPC sees rising small molecule litigation with Pfizer in the hot seat
29 August 2025
Europe
Astellas win strengthens blockbuster drug's European position
20 August 2025

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Former pharma GC brings in-house perspective to McGuireWoods
Sandoz eyes US biosimilar launch as Regeneron settles
Killing the golden goose of US drug innovation (Part I): Follow the money
Buchalter brings in new partner to head up medtech
Trump’s march-in rights threat: Why pharma is rethinking collaborations
UK gets new IP minister following cabinet reshuffle
Barnes & Thornburg reveals five new IP leaders